Presentation is loading. Please wait.

Presentation is loading. Please wait.

Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification  Jacek Jassem, MDa, Jan.

Published byCoral Glenn Modified over 5 years ago

Similar presentations

Presentation on theme: "Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification  Jacek Jassem, MDa, Jan."— Presentation transcript:

1 Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification  Jacek Jassem, MDa, Jan Skokowski, MDb, Rafał Dziadziuszko, MDa, Ewa Jassem, MDc, Amelia Szymanowska, BScc, Witold Rzyman, MDb, Andrzej Roszkiewicz, MDd  The Journal of Thoracic and Cardiovascular Surgery  Volume 119, Issue 6, Pages (June 2000) DOI: /mtc Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Probability of survival according to clinical stage. Stage IIA is not presented because of a limited number of patients. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Probability of survival in the T3 N0 category (n = 55) and stage IIIA (n = 154; T3 N0 vs IIIA: P = .03 and P = .02 for Wilcoxon and log-rank test, respectively). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Probability of survival in stage IIIA subcategories: T3 N1 (n = 26), T1-2 N2 (n = 95), and T3 N2 (n = 33). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification  Jacek Jassem, MDa, Jan."

Similar presentations

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.

A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.
Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients 

Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients 
Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,

Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.

Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer  Walter Weder, MD, Stéphane Collaud, MD,

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer  Walter Weder, MD, Stéphane Collaud, MD,
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
Rodney J. Landreneau, MDa, David J. Sugarbaker, MDb, Michael J

Rodney J. Landreneau, MDa, David J. Sugarbaker, MDb, Michael J
Refining esophageal cancer staging

Refining esophageal cancer staging

Similar presentations

Ads by Google